Corpus ID: 77801785

How should we manage infants at risk for group B streptococcal disease

  title={How should we manage infants at risk for group B streptococcal disease},
  author={M. Carlough and K. Crowell and R. Nicholas},
  journal={Journal of Family Practice},
  • M. Carlough, K. Crowell, R. Nicholas
  • Published 2003
  • Medicine
  • Journal of Family Practice
  • Asymptomatic term infants whose mothers received adequate intrapartum antibiotic prophylaxis (defined as intravenous penicillin or ampicillin at least 4 hours before delivery) for group B streptococcal disease do not need work-up or treatment (strength of recommendation [SOR]: B, based on retrospective, population-based study). These infants should be observed for 48 hours, but may be discharged after 24 hours in circumstances where close follow-up is available (SOR: D, based on expert opinion… CONTINUE READING

    Topics from this paper.


    A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.
    • 537
    Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.
    • 2,053
    • PDF
    Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta.
    • 228
    The Development of a Group B Streptococcus Prevention Policy at a Community Hospital
    • 7
    • PDF
    Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy.
    • 87
    Estimating national incidence of group B streptococcal disease: the effect of adjusting for birth weight.
    • 8